Murakami S, Isobe Y, Kijima H, Nagai H, Muramatu M, Otomo S
Research Center, Taisho Pharmaceutical Co. Ltd., Saitama, Japan.
Planta Med. 1991 Aug;57(4):305-8. doi: 10.1055/s-2006-960103.
The effects of ellagic acid on gastric H+, K(+)-ATPase, acid secretion, and the occurrence of gastric ulcers were studied. Ellagic acid inhibited hog gastric H+, K(+)-ATPase activity with a 50% inhibition at 2.1 x 10(-6)M; kinetic studies showed that the inhibition of H+, K(+)-ATPase by ellagic acid is competitive with respect to ATP and is noncompetitive with respect to K+. The effect on gastric ulcers was investigated by using a stress ulcer model. Intraperitoneal administration of ellagic acid at above 5 mg/kg markedly reduced the occurrence of gastric lesion. Ellagic acid significantly reduced acid secretion at the same doses. These results suggest that ellagic acid has a marked inhibitory effect on acid secretion and the occurrence of stress-induced gastric lesions, and these effects may be attributed to the inhibition of H+, K(+)-ATPase activity.
研究了鞣花酸对胃H⁺,K⁺ - ATP酶、胃酸分泌及胃溃疡发生的影响。鞣花酸抑制猪胃H⁺,K⁺ - ATP酶活性,在2.1×10⁻⁶M时抑制率达50%;动力学研究表明,鞣花酸对H⁺,K⁺ - ATP酶的抑制作用对ATP而言是竞争性的,对K⁺而言是非竞争性的。采用应激性溃疡模型研究了其对胃溃疡的影响。腹腔注射5mg/kg以上剂量的鞣花酸可显著减少胃损伤的发生。相同剂量下,鞣花酸可显著减少胃酸分泌。这些结果表明,鞣花酸对胃酸分泌及应激性胃损伤的发生具有显著抑制作用,且这些作用可能归因于对H⁺,K⁺ - ATP酶活性的抑制。